PMID- 25079084 OWN - NLM STAT- MEDLINE DCOM- 20150409 LR - 20220410 IS - 1488-2434 (Electronic) IS - 1180-4882 (Print) IS - 1180-4882 (Linking) VI - 39 IP - 5 DP - 2014 Sep TI - BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice. PG - 348-59 AB - BACKGROUND: Although previous study has demonstrated that brain-derived neurotrophic factor (BDNF) is involved in the antidepressant-like effect of oleanolic acid, there is little information regarding the details of the molecular mechanism involved in this effect. METHODS: We used a chronic unpredictable mild stress (CUMS) model to test the antidepressant-like effect of oleanolic acid on depressant-like behaviour, miR-132 expression and synaptic protein expression in the male mouse hippocampus. Furthermore, we explored the possible signalling pathways associated with miR-132 expression that mediate the effect of oleanolic acid on neuronal proliferation. RESULTS: The results demonstrated that a 3-week treatment with oleanolic acid ameliorated CUMS-induced anhedonic and anxiogenic behaviours. Furthermore, we found that oleanolic acid led to the BDNF-related phosphorylation and activation of extracellular signal-regulated kinases (ERK) and cyclic adenosine monophosphate response element binding protein (CREB), which was associated with the upregulation of miR-132 and hippocampal neuronal proliferation. Moreover, experiments with an miR-132 antagomir revealed that targeting miR-132 led to inhibition of neuronal proliferation and the postsynaptic density protein 95, but did not affect presynaptic protein synapsin I. LIMITATIONS: Several other stimuli can also induce CREB phosphorylation in the hippocampus. Thus, regulation of miR-132 may not be restricted to neurotrophic signalling. CONCLUSION: Our results show that oleanolic acid induces the upregulation of miR-132, which serves as an important regulator of neurotrophic actions, mainly through the activation of the hippocampal BDNF-ERK-CREB signalling pathways. FAU - Yi, Li-Tao AU - Yi LT AD - The Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, China. FAU - Li, Jing AU - Li J AD - The Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, China. FAU - Liu, Bin-Bin AU - Liu BB AD - The Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, China. FAU - Luo, Liu AU - Luo L AD - The Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, China. FAU - Liu, Qing AU - Liu Q AD - The Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, China. FAU - Geng, Di AU - Geng D AD - The Department of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Canada TA - J Psychiatry Neurosci JT - Journal of psychiatry & neuroscience : JPN JID - 9107859 RN - 0 (Antidepressive Agents) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Creb1 protein, mouse) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Disks Large Homolog 4 Protein) RN - 0 (Dlg4 protein, mouse) RN - 0 (MIRN132 microRNA, mouse) RN - 0 (Membrane Proteins) RN - 0 (MicroRNAs) RN - 6SMK8R7TGJ (Oleanolic Acid) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - EC 2.7.4.8 (Guanylate Kinases) SB - IM MH - Animals MH - Antidepressive Agents/*pharmacology MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Chronic Disease MH - Cyclic AMP Response Element-Binding Protein/*metabolism MH - Depressive Disorder/drug therapy/physiopathology MH - Disease Models, Animal MH - Disks Large Homolog 4 Protein MH - Extracellular Signal-Regulated MAP Kinases/*metabolism MH - Guanylate Kinases/metabolism MH - Hippocampus/drug effects/physiopathology MH - Male MH - Membrane Proteins/metabolism MH - Mice, Inbred ICR MH - MicroRNAs/*metabolism MH - Neurogenesis/drug effects/physiology MH - Neurons/drug effects/physiology MH - Oleanolic Acid/*pharmacology MH - Random Allocation MH - Signal Transduction/drug effects MH - Stress, Psychological MH - Uncertainty MH - Up-Regulation/drug effects PMC - PMC4160364 EDAT- 2014/08/01 06:00 MHDA- 2015/04/10 06:00 PMCR- 2014/09/01 CRDT- 2014/08/01 06:00 PHST- 2014/08/01 06:00 [entrez] PHST- 2014/08/01 06:00 [pubmed] PHST- 2015/04/10 06:00 [medline] PHST- 2014/09/01 00:00 [pmc-release] AID - 10.1503/jpn.130169 [pii] AID - jpn-39-348 [pii] AID - 10.1503/jpn.130169 [doi] PST - ppublish SO - J Psychiatry Neurosci. 2014 Sep;39(5):348-59. doi: 10.1503/jpn.130169.